Robot suit aims to get kids with disabilities walking

NCT ID NCT07159360

Not yet recruiting Symptom relief Sponsor: MarsiBionics Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tests a robotic exoskeleton called CLINICAL EXPLORER in 60 children aged 2 to 17 with neurodevelopmental disorders like cerebral palsy. The device supports walking during 8 therapy sessions. Researchers will check if it is safe, easy to use, and helps improve movement and quality of life.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: CLINICAL EXPLORER robotic gait exoskeleton
What this could lead to: If successful, this exoskeleton could provide a safe and effective way to improve walking ability and quality of life for children with conditions like cerebral palsy.
What could go wrong: This is an early-stage study with only 60 participants, focused on safety and usability. The device may not work for all children, and there is a risk of falls or skin irritation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LEUKODYSTROPHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

brain injury cerebral palsy leukodystrophy multiple sclerosis neurodevelopmental disorder neuromuscular disease spinal cord injury spinal muscular atrophy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

NEURODEVELOPMENTAL DISORDERS NEUROMUSCULAR DISORDERS

Contacts and locations

Locations

Asociación Pro Personas con Paralisis Cerebral (APAC-IAP)

Mexico City, Mexico City, 06720, Mexico
Hospital Infantil Universitario Niño Jesús-Servicio de Neuro Ortopedia

Madrid, Madrid, 28009, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.